Clinical Trial Update: Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation

View source ↗

Summary

A completed clinical trial investigated whether genetic mutations in blood and tissue can predict response to chemoradiation in locally advanced rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucinous Adenocarcinoma of the Rectum
• Rectal Cancer
• Signet Ring Cell Carcinoma of the Rectum

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Mucinous Adenocarcinoma of the Rectum, Recurrent Rectal Cancer | Status: COMPLETED